Hospital São Lucas PUCRS

Porto Alegre, Rio Grande do Sul 90619-900

0 studies enrolling now · 5 studies all time

What they study most

Acute Myocardial Infarction (AMI), COVID-19, Cardiovascular Diseases, Cardiovascular Risk, Cardiovascular Risk Factor, Coronavirus Disease 2019 (COVID-19) Pneumonia, Growth Hormone Deficiency in Children, Growth Hormone Disorder, Metastatic Pancreatic Adenocarcinoma

Studies at this site

• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors — Stopped early
• Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency — Completed
• Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19 — Status unconfirmed
• A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) — Completed